HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Return
11.46%
This Quarter Return
-0.12%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.74B
AUM Growth
+$142M
(+8.9%)
Cap. Flow
+$167M
Cap. Flow
% of AUM
9.58%
Top 10 Holdings %
Top 10 Hldgs %
58%
Holding
52
New
15
Increased
12
Reduced
9
Closed
12
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$157M |
| 2 |
Intuitive Surgical
ISRG
|
$111M |
| 3 |
AET
Aetna Inc
AET
|
$104M |
| 4 |
Quest Diagnostics
DGX
|
$88.8M |
| 5 |
Danaher
DHR
|
$78.2M |
Top Sells
| 1 |
Biogen
BIIB
|
$117M |
| 2 |
Edwards Lifesciences
EW
|
$109M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$77.1M |
| 4 |
Cigna
CI
|
$76M |
| 5 |
Eli Lilly
LLY
|
$66.2M |
Sector Composition
| 1 | Healthcare | 82.12% |
| 2 | Financials | 5.97% |
| 3 | Consumer Staples | 3.94% |
| 4 | Materials | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRAH
26
DELISTED
PRA Health Sciences, Inc.
PRAH
| $16.5M | 0.93% |
300,000
-375,000
| -56% | -$20.7M |
|
27
Medpace
MEDP
$13.6B
| $15.3M | 0.87% |
425,000
+98,315
| +30% | +$3.55M |
|
|
CVRS
28
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $14M | 0.79% |
19,981,655
| – | – |
|
29
Thermo Fisher Scientific
TMO
$185B
| $13.4M | 0.76% |
+94,980
| New | +$13.4M |
|
|
MON
30
DELISTED
Monsanto Co
MON
| $13.2M | 0.74% |
+125,000
| New | +$13.2M |
|
31
Baxter International
BAX
$12.1B
| $13M | 0.74% |
+293,650
| New | +$13M |
|
32
HCA Healthcare
HCA
$96.3B
| $11.6M | 0.66% |
157,260
+67,520
| +75% | +$5M |
|
33
Globus Medical
GMED
$8.14B
| $11.2M | 0.63% |
+450,000
| New | +$11.2M |
|
34
Align Technology
ALGN
$9.76B
| $9.83M | 0.56% |
+102,263
| New | +$9.83M |
|
|
SPNE
35
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $5.07M | 0.29% |
641,700
+9,600
| +2% | +$75.8K |
|
36
Natera
NTRA
$22.9B
| $3.51M | 0.2% |
299,300
+4,500
| +2% | +$52.7K |
|
37
Revvity
RVTY
$9.95B
| $2.3M | 0.13% |
+44,150
| New | +$2.3M |
|
38
Arbutus Biopharma
ABUS
$769M
| – | – |
-2,000,000
| Closed | -$6.88M |
|
39
Acadia Healthcare
ACHC
$2.18B
| – | – |
-770,000
| Closed | -$38.2M |
|
40
AMN Healthcare
AMN
$775M
| – | – |
-132,481
| Closed | -$4.22M |
|
|
41
Biogen
BIIB
$20.5B
| – | – |
-375,000
| Closed | -$117M |
|
42
Cardinal Health
CAH
$35.7B
| – | – |
-525,000
| Closed | -$40.8M |
|
|
43
Edwards Lifesciences
EW
$47.5B
| – | – |
-2,700,000
| Closed | -$109M |
|
44
Amicus Therapeutics
FOLD
$2.47B
| – | – |
0
| – | – |
|
45
Gilead Sciences
GILD
$140B
| – | – |
0
| – | – |
|
|
46
Eli Lilly
LLY
$666B
| – | – |
-825,000
| Closed | -$66.2M |
|
47
Perrigo
PRGO
$3.2B
| – | – |
-197,300
| Closed | -$18.2M |
|
|
VAR
48
DELISTED
Varian Medical Systems, Inc.
VAR
| – | – |
0
| – | – |
|
|
MNK
49
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – |
-875,000
| Closed | -$61.1M |
|
|
AGN
50
DELISTED
Allergan plc
AGN
| – | – |
-57,550
| Closed | -$13.3M |
|